Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Trends in Microbiology|October 8, 2018
HIV-1 Latency Is Maintained by the Estrogen ReceptorAlexis J Bick, Janet P Hapgood
Steroids|August 14, 2022
Variability and quantification of serum medroxyprogesterone acetate levelsAlexis J Bick, Salndave B Skosana, Chanel Avenant, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 27, 2022
Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanismsAlexis J Bick, Chanel Avenant, Michele Tomasicchio, et al.
Pharmacology & Therapeutics|December 14, 2020
Pharmacokinetics, metabolism and serum concentrations of progestins used in contraceptionAlexis J Bick, Renate Louw-du Toit, Salndave B Skosana, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 11, 2025
Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 AcquisitionChanel Avenant, Alexis J Bick, Johnson M Moliki, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2019
Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function <i>In Vitro</i>Sigcinile Dlamini, Michael Kuipa, Kim Enfield, et al.
Biology of Reproduction|January 5, 2026
Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†Alexis J Bick, Chanel Avenant, Carole-Keza Capitaine, et al.
Pageof 2